Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Spark Therapeutics Inc

CUSIP: 84652J903 | 10 institutional holders

Quarters

Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile